Lilly announces positive trial results for its pill form GLP-1 medication, paving the way for global regulatory approval this ...

In 2024, 26.5% of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables.

Male and female fat deposit distribution was associated with an increased cardiovascular age-delta; however, some adiposity ...

The results of the ATTAIN-2 study, which involved people with obesity or overweight and type 2 diabetes, showed that the oral ...

Stock index futures fell on Tuesday, as President Donald Trump fired Federal Reserve Governor Lisa Cook on Monday amid ...

Daily weight loss pill achieves main goal in late-stage trial - Data from an earlier study of the drug in patients without diabetes sent company shares tumbling ...